EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
EQHA.WS was delisted on the 25th of November, 2022.
43 hedge funds and large institutions have $5.57M invested in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
1,050% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 2
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
95% more funds holding
Funds holding: 22 → 43 (+21)
74% more capital invested
Capital invested by funds: $3.2M → $5.57M (+$2.37M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$170K |
| 2 |
DKCM
Davidson Kempner Capital Management
New York
|
+$142K |
| 3 |
MCM
Moore Capital Management
New York
|
+$84.9K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$84.9K |
| 5 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
+$84.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$50K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$38.2K |
| 3 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$36.8K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$19K |
EQHA.WS Hedge Fund Activity: Q2 2021 in Review
43 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) for Q2 2021, worth a combined $5.57M — up 74% from $3.2M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new EQHA.WS positions and 2 closed out — a net gain of 21 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Periscope Capital, opening a new position worth an estimated $170K. The largest seller was Saba Capital Management, exiting entirely with an estimated $50K sold.
- 43 institutional investors held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) as of Q2 2021, up from 22 in Q1 2021.
- Funds reported $5.57M of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q2 2021, up 74% quarter-over-quarter.
- 23 funds opened new EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q2 2021 and 2 closed out, a net change of +21 holders.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q2 2021 was Periscope Capital, an estimated $170K added.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q2 2021 was Saba Capital Management, an estimated $50K sold.
Based on aggregated 13F filings for Q2 2021.